The comparison between free thyroxine and thyroid-stimulating hormone levels on melasma severity: A cross-sectional study

2Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

BACKGROUND: Melasma has been suspected to be linked with levels of thyroid hormone. There is no study that explains the association between thyroid hormone levels with melasma severity. AIM: This study aims to find the discrepancies in the levels of thyroid hormone in varying severity of melasma using two different measurement techniques. METHODS: Subjects were chosen consecutively from the dermatology clinic at RSUPN Dr. Cipto Mangunkusumo hospital. Forty-eight patients participated in this study were categorized into mild melasma and moderate-severe melasma based on modified melasma area and severity index (mMASI) and Janus II measurement. RESULTS: Statistically, mMASI measurement showed no significant association between varying melasma severity with levels of thyroid stimulating hormone and free T4 (FT4), p = 0.375 and p = 0.208, respectively. The Janus II examination using polarized light modality has a weak positive correlation with the serum FT4 level (r = 0.3; p = 0.039). Weak correlation was also found between the two measurement strategies, Janus II and mMASI (r = 0.314; p = 0.03). CONCLUSION: There are no significant differences observed in levels of thyroid hormone between subjects with varying degrees of melasma severity.

Cite

CITATION STYLE

APA

Rahman, Y., Krisanti, R. I. A., Wisnu, W., & Sitohang, I. B. S. (2021). The comparison between free thyroxine and thyroid-stimulating hormone levels on melasma severity: A cross-sectional study. Open Access Macedonian Journal of Medical Sciences, 9, 426–431. https://doi.org/10.3889/oamjms.2021.5952

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free